RecruitingPhase 3NCT06553443

Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis


Sponsor

Singapore General Hospital

Enrollment

94 participants

Start Date

Jan 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the access circuit primary patency after Ranger drug-coated balloon angioplasty of arteriovenous fistula (AVF) stenosis with that after conventional balloon angioplasty


Eligibility

Min Age: 21 Years

Inclusion Criteria5

  • Failing AVF with at least 1 AVF stenosis presenting with any clinical, physiological or haemodynamic abnormalities. Both de novo and recurrent stenosis are accepted.
  • AVF has been used successfully for at least 1 month (non-mature AVF are not allowed).
  • Less than 30% residual stenosis after angioplasty.
  • ≥ 21 years old
  • Informed and valid consent given.

Exclusion Criteria10

  • Thrombosed AVFs
  • Haemodynamically significant central vein stenosis
  • Target lesion not treatable with the available sizes of drug eluting balloon (up to 8mm)
  • Contraindication to antiplatelet therapy
  • Coagulopathy or thrombocytopenia that cannot be managed adequately with periprocedural transfusion.
  • Allergy / contraindication to paclitaxel.
  • Acute infection over proposed puncture site.
  • Women who are breastfeeding, pregnant * or planning on becoming pregnant during study.
  • Participant with medical conditions, which in the opinion of the investigator may cause noncompliance with protocol.
  • Currently participating in an investigational drug, biologic or device trial that may have an impact on the dialysis access or previous enrolment in this study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAngioplasty of all peripheral AVF stenosis

All peripheral AVF stenosis are to be treated with the same type of balloon depending on allocation


Locations(1)

Singapore General Hospital

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06553443


Related Trials